Fish oil therapy: Gaining credibility

Future Cardiology

Volumn 5, Issue 6, 2009, Pages 533-539

  Lavie, Carl J ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ANTIARRHYTHMIC ACTIVITY; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION COST; HUMAN; LOW DRUG DOSE; MORTALITY; NONHUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; PRIMARY PREVENTION; SECONDARY PREVENTION;

EID: 74049126634     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.48     Document Type: Note

References (8)

1. Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J. Am. Coll. Cardiol. 54 (7) 585-594 (2009).
2. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [errata in Lancet 357, 642, 2001 and Lancet 369, 106, 2003].
3. Lancet 354, 447-55 (1999).
4. GISSI-HF Investigators: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial) : a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230 (2009).
5. Yokoyama M, Origasa H, Matsuzaki M et al.: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS) : a randomised open-label, blinded endpoint analysis [published correction appears in Lancet 370, 220, 2007]. Lancet 369, 1090-8 (2007).
6. Yokoyama M, Origasa H; JELIS Investigators: Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 146 (4), 613-620 (2003).
7. Harris WS, Poston WC, Haddock CK: Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (1), 1-10 (2007).
8. Lavie CJ, Milani RV, Ventura HC: Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53, 1925-1932 (2009).